NUAK2 and glioblastoma: In contrast, RNA-sequencing data from The Cancer Genome Atlas (TCGA) indicate that NUAK2 expression is markedly elevated in GBM patients, while normal brain tissues display only minimal expression levels (Fig. 1B).